2020 / 02

Next Paper
DOI: 10.24075/brsmu.2020.022

METHOD

Synthesis of 13С- and 14С-labeled linoleic acids for use in diagnostic breath tests for hepatobiliary system disorders

Tynio YaYa1, Morozova GV2, Biryukova YuK3, Sivokhin DA4, Pozdniakova NV5, Zylkova MV3, Bogdanova ES3, Smirnova MS3, Shevelev AB3,6
About authors

1 Russian State University of Physical Education, Sport, Youth and Tourism, Moscow, Russia

2 Skryabin Moscow State Academy of Veterinary Medicine and Biotechnology, Moscow

3 Vavilov Institute of General Genetics, Russian Academy of Sciences, Moscow, Russia

4 I. M. Sechenov First Moscow State Medical University, Moscow, Russia

5 Blokhin National Medical Research Center of Oncology, Moscow, Russia

6 Plekhanov Russian University of Economics, Moscow, Russia

Correspondence should be addressed: Yaroslav Y. Tynio
Sirenevyi bulvar, 4, Moscow, 105122; ur.liam@oinytyy

About paper

Author contribution: Tynio YY conceived and supervised the study; Morozova GV synthesized the final product by carboxylation of the Grignard reagent with 13С and 14С dioxides, did preparative calculations; Biryukova YuK conducted NMR-analysis of the final product; Sivokhin DA analyzed the literature and wrote the manuscript; Pozdniakova NV analyzed the literature; Zylkova MV measured the radioactivity of carbon atoms in the reagents, intermediate and final products; Bogdanova ES analyzed the NMR spectra of the final products; Smirnova MS determined the melting point of the final products; Shevelev AB provided reagents and instrumentation and revised the manuscript.

Received: 2020-03-31 Accepted: 2020-04-15 Published online: 2020-04-25
|
  1. Liou IW. Management of end-stage liver disease. Med Clin North Am. 2014; 98 (1): 119–52. DOI: 10.1016/j.mcna.2013.09.006.
  2. Musialik J, Jonderko K, Kasicka-Jonderko A, Buschhaus M. 13CO2 breath tests in non-invasive hepatological diagnosis. Prz Gastroenterol. 2015; 10 (1): 1–6.
  3. Modak AS. Stable isotope breath tests in clinical medicine: A review. J Breath Res. 2007; 1 (1): R1–R13. DOI: 10.1088/1752- 7155/1/1/014003.
  4. Razlan H, Marzuki NM, Tai M-L S, Shamsul Tze-Zen Ong A-S, Mahadeva S. Diagnostic value of the 13C-methacetin breath test in various stages of chronic liver disease. Gastroenterol Res Pract. 2011; 2011 (1): 1–6. DOI: 10.1155/2011/235796.
  5. Forns X, Ampurdanès S, Llovet JM, Aponte J, Quintó L, Martínez- Bauer E, et al. Identification of chronic hepatitis C patients without hepatic fibrosis by a simple predictive model. Hepatology, 2002; 36 (4I): 986–92. DOI: 10.1053/jhep.2002.36128.
  6. Wai CT, Greenson KJ, Fontana RJ, Kalbfleisch JD, Jorge AM, Hari SC, et al. A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C. Hepatology. 2003; 38 (2): 518–26. DOI: 10.1053/ jhep.2003.50346.
  7. Elman AR, Rapoport SI. Stabil'no-izotopnaja diagnostika v Rossii: itogi i perspektivy. 13С-preparaty, pribory, metody. Klin med. 2014; 92 (7): 5–11. Russian.
  8. Balãn H, Gold CA, Dworkin HJ, McCormick VA, Freitas JE. Procedure Guideline for Carbon-14-Urea Breath Test. J Nucl Med. 2016; 39 (11): 2012–14.
  9. Plavnik RG. 13S-Ureaznyj dyhatel'nyj test na Helicobacter pylori (klinicheskie i organizacionnye aspekty). M.: MEDPRAKTIKA-M, 2017; 36 s.
  10. Grattagliano I, Lauterburg BH, Palasciano G, and Portincasa P. 13C-breath tests for clinical investigation of liver mitochondrial function. Eur J Clin Invest. 2010; 40 (9): 843–50. DOI: 10.1111/j.1365-2362.2010.02331.x.
  11. Gorowska-Kowolik K, Chobot A, and Kwiecien J. 13C-Methacetin Breath Test for Assessment of Microsomal Liver Function: Methodology and Clinical Application. Gastroenterol Res Pract. 2017; 2017 (1): 1–5.
  12. Moran S, Mina A, Duque X, Ortiz-Olvera N, Rodriguez-Leal G, Sierra-Ramírez JA, et al. The utility of the 13C-methacetin breath test in predicting the long-term survival of patients with decompensated cirrhosis. J Breath Res. 2017; 11 (3): 1–28. DOI: 10.1088/1752- 7163/aa7b99.
  13. Elman AR, Korneeva GA, Noskov YuG, Khan VN, Shishkina EYu, Negrimovski VM, Syntheses of products labeled with 13С isotope for medicine diagnosis. Russian Chemical Journal. 2013; LVII (5): 3–24.
  14. Giannini EG, Alberto F, Paolo B, Federica B, Federica M, et al. 13C-galactose breath test and 13C-aminopyrine breath test for the study of liver function in chronic liver disease. Clin Gastroenterol Hepatol. 2005; 3 (3): 279–85. DOI: 10.1016/S1542-3565(04)00720-7.
  15. Moran S, Gallardo-Wong I, Rodriguez-Leal G, McCollough P, Mendez J, Castañeda B, et al. L-[1-13C]phenylalanine breath test in patients with chronic liver disease of different etiologies. Isotopes Environ Health Stud. 2009; 45 (3): 192–7. DOI: 10.1080/10256010903083995.
  16. Zhang GS, Bao ZJ, Zou J, Yin SM, Huang YQ, Huang H, et al. Clinical research on liver reserve function by 13C-phenylalanine breath test in aged patients with chronic liver diseases. BMC Geriatr. 2010; 10 (23): 1–8 . DOI: 10.1186/1471-2318-10-23.
  17. Schmilovitz-Weiss H, Niv Y, Pappo O, Halpern M, Sulkes J, Braun M, et al. The 13C-caffeine breath test detects significant fibrosis in patients with nonalcoholic steatohepatitis. J Clin Gastroenterol. 2008; 42 (4): 408–12, 2008. DOI: 10.1097/ MCG.0b013e318046ea65.
  18. Gordon J, Park H, Wiseman E, George J, Katelaris PH, Seow F, et al. Non-invasive estimation of liver fibrosis in non-alcoholic fatty liver disease using the 13C-caffeine breath test. J Gastroenterol Hepatol. 2011; 26 (9): 1411–6. DOI: 10.1111/j.1440- 1746.2011.06760.x.
  19. Braden B. 13C breath tests for the assessment of exocrine pancreatic function. Pancreas. 2010; 39 (7): 955–9. DOI: 10.1097/ MPA.0b013e3181dbf330.
  20. Titov VN. Klinicheskaja biohimija zhirnyh kislot, lipidov i lipoproteinov. Gipolipidemicheskaja terapija i profilaktika ateroskleroza. Kliniko-laboratornyj konsilium. 2014; 1: 4–29. Russian.
  21. Georgin D, Taran F, Mioskowski C. A divergent synthesis of [1-14C]-mono-E isomers of fatty acids. Chem Phys Lipids. 2003; 125 (1): 83–91.
  22. Kawashima H, Akimoto K, Tsuyoshi F, Hideo N, Kyoko K, Sakayu S. Preparation of 13C-labeled polyunsaturated fatty acids by an arachidonic acid-producing fungus Mortierella alpina 1S-4. Analytical Biochemistry. 1995; 229 (2): 317–22. DOI: 10.1006/ abio.1995.1419.
  23. Zhao X, Qiu X. Analysis of the biosynthetic process of fatty acids in Thraustochytrium. Biochimie. 2018; 144 (1): 108–14.
  24. Lide DR. CRC Handbook of Chemistry and Physics. 86th ed. CRC Press. 2006; p. 3–320.
  25. Pozdeev VV, Tyño YJ, Morozova GV, Bychenko AB, Biryukova YK, Shevelev AB; LLC "GK Our World". Method of Synthesis of Linoleic and Linolenic Acids Labeled with Carbon Isotopes 13С and 14С. RF Patent # 2630691. 12.09.2017.
  26. Shaaban M, Abd-Alla HI, Hassan AZ, Aly HF, Ghani MA. Chemical characterization, antioxidant and inhibitory effects of some marine sponges against carbohydrate metabolizing enzymes. Org Med Chem Lett. 2012; 2 (1): 30.
  27. Mironov AN. Rukovodstvo po provedeniju doklinicheskih issledovanij lekarstvennyh sredstv. M.: Grif i K, 2012; 994 s.